瑞普生物入选中上协“2023年报业绩说明会最佳实践案例”

Core Viewpoint - RuiPu Bio was awarded the "Best Practice of Annual Report Performance Briefing" by the China Listed Companies Association, highlighting its innovative practices in investor relations management [1] Group 1: Investor Relations Management - Since its listing in 2010, RuiPu Bio has adhered to the principle of integrity and views investor relations management as a crucial part of corporate governance [2] - The company has optimized its investor communication mechanisms and expanded communication channels through various methods, including legal information disclosure, performance briefings, and social media platforms [2] Group 2: Annual Performance Briefing - During the 2023 annual performance briefing on April 23, 2024, the chairman and management team engaged with investors and analysts through a combination of in-person and live-streaming formats, discussing achievements in strategy execution, operational development, and investor returns [3] - The live-streaming format allowed for direct interaction between management and investors, significantly enhancing investor confidence and understanding of the company [3] Group 3: Sustainable Development and Governance - RuiPu Bio is committed to green development, focusing on the research and development of environmentally friendly products, achieving a balance between economic and social benefits [4] - The company has improved its windESG rating from BB to A, ranking first in its industry segment, and has disclosed ESG reports for two consecutive years [4] - RuiPu Bio aims to strengthen transparency and accuracy in information disclosure and enhance corporate governance to build a more reputable and transparent corporate image [4]